Skip to content

Other ways to search: Events Calendar | UTHSC News

Core Publications

CORE PUBLICATIONS IN RECENT FIVE YEARS (2018 - 2022)

(Investigators are indicated in bold font, the Core Director is underlined)

2022
Hu Z, Han L, Liu J, Fowke JH, Han JC, Kakhniashvili D, LeWinn KZ, Bush NR, Mason WA, Zhao Q. Prenatal Metabolomic Profiles Mediate the Effect of Maternal Obesity On Early Childhood Growth Trajectories and Obesity Risk: the CANDLE Study. Am J Clin Nutr. 2022 Sep 2; 116(5):1343-53. doi: 10.1093/ajcn/nqac244. PMID: 36055779. [Full Text]
 
Zheng S, Liu J, Kang B, Wang G. Design and synthesis of a novel ZB716-d6 as a stable isotopically labeled internal standard. Synth Commun. 2022; 52(11-12):1441-1447. doi: 10.1080/00397911.2022.2095212. PMID: 36420104. [Full Text]
 
Zhao Q, Shen H, Liu J, Chiu CY, Su KJ, Tian Q, Kakhniashvili D, Qiu C, Zhao LJ, Luo Z, Deng HW. Pathway-based metabolomics study of sarcopenia-related traits in two US cohorts. Aging (Albany NY). 2022 Mar 2; 14(5):2101-2112. doi: 10.18632/aging.203926. PMID: 35235538. [Full Text]
2021
Sluter MN, Hou R, Li L, Yasmen N, Yu Y, Liu J, Jiang J. EP2 Antagonists (2011-2021): A Decade's Journey from Discovery to Therapeutics. J Med Chem. 2021 Aug 26; 64(16):11816-11836. doi: 10.1021/acs.jmedchem.1c00816. PubMed PMID: 34352171. [Full Text]
 
Lu Y, Peng Z, Zhu D, Jia Y, Taledaohan A, Li Y, Liu J, Wang Y, Wang Y. RGD Peptide and PAD4 Inhibitor-Loaded Gold Nanorods for Chemo-Photothermal Combined Therapy to Inhibit Tumor Growth, Prevent Lung Metastasis and Improve Biosafety. Int J Nanomedicine. 2021 Aug 16; 16:5565-5580. doi: 10.2147/IJN.S319210. eCollection 2021.PMID: 34429600 [Full Text]
 
Sluter MN, Hou R, Li L, Yasmen N, Yu Y, Liu J, Jiang J. EP2 Antagonists (2011-2021): A Decade's Journey from Discovery to Therapeutics. J Med Chem. 2021 Aug 5;. doi: 10.1021/acs.jmedchem.1c00816. [Epub ahead of print] PubMed PMID: 34352171. [Full text]
 
Liu J, Rajasekaran N, Hossain A, Zhang C, Guo S, Kang B, Jung H, Kim H, Wang G. Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME Studies. Pharmaceuticals (Basel). 2021 Jul 26; 14(8):719. doi: 10.3390/ph14080719. PMID: 34451816. [Full Text]
 
Zhao Q, Hu Z, Kocak M, Liu J, Fowke JH, Han JC, Kakhniashvili D, Lewinn KZ, Bush NR, Mason WA, Tylavsky FA. Associations of prenatal metabolomics profiles with early childhood growth trajectories and obesity risk in African Americans: the CANDLE study. Int J Obes (Lond). 2021 Jul;45(7):1439-1447. doi: 10.1038/s41366-021-00808-3. Epub 2021 Apr 6. PubMed PMID: 33824402. [Full text] 
 
Lu Y, Zhu D, Gui L, Li Y, Wang W, Liu J, Wang Y. A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis via the PARP/ATM pathway. J Nanobiotechnology. 2021 Apr 23;19(1):115. doi: 10.1186/s12951-021-00799-3. PubMed PMID: 33892746; PubMed Central PMCID: PMC8063440. [Full Text] 
 

Xiao Z, Liu J, Liu SH, Petridis L, Cai C, Cao L, Wang G, Chin AL, Cleveland JW, Ikedionwu MO, Carrick JD, Smith JC, Quarles LD. Novel Small Molecule Fibroblast Growth Factor 23 Inhibitors Increase Serum Phosphate and Improve Skeletal Abnormalities in Hyp Mice. Mol Pharmacol. 2021 Jun; 101(6):408-421. doi: 10.1124/molpharm.121.000471. Epub 2022 Mar 26.PMID: 35339985. [Full Text]

2020
Chen J, Goyal N, Dai L, Lin Z, Del Valle L, Zabaleta J, Liu J, Post SR, Foroozesh M, Qin Z. Developing new ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated lymphoma. Blood. 2020 Nov 5;136(19):2175-2187. doi: 10.1182/blood.2020005569. PubMed PMID: 32518949; PubMed Central PMCID: PMC7645984. [Full text]
 
Yang D, Taylor ZE, Handy S, Li S, Liu J, Stabenow J, Zalduondo L, Jonsson CB, Altman E, Kong Y. Identification of Anti-tuberculosis Compounds From Aurone Analogs. Front Microbiol. 2020;11:1004. doi: 10.3389/fmicb.2020.01004. eCollection 2020. PubMed PMID: 32508798; PubMed Central PMCID: PMC7251074. [Full text] 
 
Guo S, Zhang C, Mottamal M, Hossain A, Liu J, Wang G. GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models. Breast Cancer Res Treat. 2020 Apr;180(2):359-368. doi: 10.1007/s10549-020-05558-w. Epub 2020 Feb 6. PubMed PMID: 32030569; PubMed Central PMCID: PMC7069796. [Full text] 
2019
Yang D, He X, Li S, Liu J, Stabenow J, Zalduondo L, White S, Kong Y. Rv1075c of Mycobacterium tuberculosis is a GDSL-Like Esterase and Is Important for Intracellular Survival. J Infect Dis. 2019 Jul 19;220(4):677-686. doi: 10.1093/infdis/jiz169. PubMed PMID: 31001637. [Full text]
 
Foroozesh M, Sridhar J, Goyal N, Liu J. Coumarins and P450s, Studies Reported to-Date. Molecules. 2019 Apr 24;24(8). doi: 10.3390/molecules24081620. Review. PubMed PMID: 31022888; PubMed Central PMCID: PMC6515222. [Full text] 
Aug 7, 2025